1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
- 2019
- Cognitive reserve and clinical progression in Alzheimer disease : A paradoxical relationship
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum
- Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort : The ABIDE project
- Applying the ATN scheme in a memory clinic population : The ABIDE project
- Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment : the effect of age at onset
- Biomarker-based prognosis for people with mild cognitive impairment (ABIDE) : a modelling study
- Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
- 2018
- Clinical phenotype, atrophy, and small vessel disease in APOEε2 carriers with Alzheimer disease
- A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus